Respiratory Tract Diseases  >>  amikacin inhalation solution (NKTR-061)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amikacin inhalation solution (NKTR-061) / Nektar Therap
NCT01004445 / 2005-000060-16: A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Completed
2
69
US, Europe
Amikacin (BAY41-6551), Placebo
Bayer, Nektar Therapeutics
Pneumonia
06/06
06/06
NCT01021436 / 2006-005079-17: Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia

Completed
2
30
US, Europe
Amikacin inhalation solution (BAY41-6551)
Bayer, Nektar Therapeutics
Pneumonia
08/07
08/07

Download Options